Bioporto A/S (BIOPOR.CO) News|
United States

Bioporto A/S (BIOPOR.CO)

BIOPOR.CO on Copenhagen Stock Exchange

30 Jun 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Mon, May 30 2016

BRIEF-Bioporto: FDA rejects application for registration of NGAL Test

* The FDA rejects application for the registration og The NGAL Test

BRIEF-Bioporto NGAL Forms patent upheld after EPO ruling

* Says the company's NGAL Forms patent is upheld after European Patent Office (EPO) ruling

BRIEF-Bioporto Q1 EBIT widens to loss DKK 5.4 million

* Q1 revenue of 5.2 million Danish crowns ($803,101.21) compared to 4.1 million crowns in year-earlier period, corresponding to a growth of 26 percent

BRIEF-BioPorto cuts 2016 EBIT outlook due to warrants program

* Adjusts EBIT forecast for 2016 due to warrants program for employees

BRIEF-BioPorto EBIT loss narrows to DKK 12.8 mln

* FY revenues up 9 pct to 20.4 million Danish crowns ($3.03 million)

BRIEF-BioPorto enters distribution agreement with Siemens Healthcare

* Says has entered into a distribution agreement with Siemens Healthcare, under which BioPorto will deliver an NGAL test adapted for Siemens Healthcare's BN II and BN ProSpec Systems

Select another date: